TAIRX, INC.
Update：2026/03/10
Industries
Main Industry
Health Care
Main Product/Service
1. CVM-1118 (Foslinanib)
2. Zelnite®
3. TRX-NOC
4. TRX-920
5. TRX-105
2. Zelnite®
3. TRX-NOC
4. TRX-920
5. TRX-105
Founded Year
2011
Unified Business No.
53529570
Status
Active
Number of Employees
0
Total Paid-in
Capital
1,119,899,080 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
Emerging Stock Exchange(2017)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
TaiRx is an efficient Pharma Management Corporate to develop a new generation of oncology molecule.TaiRx started a series of financing and expanded the drug pipeline. In addition to cancer treatment, TaiRx also extended our reach to the therapy of other m
